• Home Alexza plans to reacquire U.

Alexza plans to reacquire U.

ADASUVE is an efficient product. There are significant challenges in launching a medical center product, especially one as complex as ADASUVE. We appreciate the efforts that Teva has designed to time and are looking forward to continuing to build the ADASUVE brand, said Thomas B. King, Alexza CEO and President. We remain assured in ADASUVE's long-term commercial plan and prospects to utilize Teva to effect a smooth transition. It is our purpose to function diligently in 2016 to identify a new U.S. Industrial partner for ADASUVE. .. Alexza plans to reacquire U.S. Rights for ADASUVE inhalation powder from Teva Alexza Pharmaceuticals, Inc. announced today that it plans to reacquire the U.S., a subsidiary of Teva Pharmaceutical Sectors Ltd., with around target completion day of January 1, 2016.An integral speaker at the function, Dr. Leonard Coldwell, has not only pulled from the event, he has posted a general public message on his Facebook page as follows: I and all my friends are pulling out of the Alive NY event based on the fact that they did not keep their promises and duties to my dear friend the co-founder of Alive NY Liana Werner-Gray. They took her money and as it sometimes appears by me they screwed Liana over. All the individuals who I contacted are pulling out of the event. This is just for your information. Please support Liana she is hurt by this betrayal and dishonesty really.